Safety of Juvista When Administered Following Excision of Ear Lobe Keloids
NCT00710333
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Keloid
Interventions
DRUG:
Avotermin
DRUG:
placebo
Sponsor
Renovo